A new mechanism by which cancers can circumvent cisplatin resistance : The E2F1/BIN1 axis
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Medecine sciences : M/S - 40(2024), 3 vom: 23. März, Seite 241-244 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Un nouveau mécanisme de la résistance des cancers au cisplatine - Rôle des protéines E2F1 et BIN1 |
---|
Beteiligte Personen: |
Pyndiah, Slovénie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adaptor Proteins, Signal Transducing |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1051/medsci/2024009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370096738 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370096738 | ||
003 | DE-627 | ||
005 | 20240325235620.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240324s2024 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1051/medsci/2024009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1347.xml |
035 | |a (DE-627)NLM370096738 | ||
035 | |a (NLM)38520097 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Pyndiah, Slovénie |e verfasserin |4 aut | |
245 | 1 | 2 | |a A new mechanism by which cancers can circumvent cisplatin resistance |b The E2F1/BIN1 axis |
246 | 3 | 3 | |a Un nouveau mécanisme de la résistance des cancers au cisplatine - Rôle des protéines E2F1 et BIN1 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Cisplatin |2 NLM | |
650 | 7 | |a Q20Q21Q62J |2 NLM | |
650 | 7 | |a Nuclear Proteins |2 NLM | |
650 | 7 | |a E2F1 Transcription Factor |2 NLM | |
650 | 7 | |a BIN1 protein, human |2 NLM | |
650 | 7 | |a Tumor Suppressor Proteins |2 NLM | |
650 | 7 | |a Adaptor Proteins, Signal Transducing |2 NLM | |
650 | 7 | |a E2F1 protein, human |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Medecine sciences : M/S |d 1996 |g 40(2024), 3 vom: 23. März, Seite 241-244 |w (DE-627)NLM08683102X |x 1958-5381 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2024 |g number:3 |g day:23 |g month:03 |g pages:241-244 |
856 | 4 | 0 | |u http://dx.doi.org/10.1051/medsci/2024009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2024 |e 3 |b 23 |c 03 |h 241-244 |